Skip to main content

Hybrid SPECT/CT and PET/CT Imaging in Infectious Diseases

  • Chapter
  • First Online:
  • 622 Accesses

Abstract

Hybrid imaging with SPECT/CT and PET/CT has had a profound impact on diagnostic imaging and in infection imaging too, combining functional information with anatomic details provided by nuclear medicine and radiological devices, respectively. In the early times, Nuclear Medicine and Radiological imaging could be co-registered or acquired separately and fused a posteriori, but artifacts in images alignment and mismatches could occur in operator-dependent manner. Currently, SPECT and PET cameras have been implemented developing new strategies and software to analyze images. In this chapter, hybrid SPECT/CT and PET/CT imaging will be described with particular focus on the technical characteristics, the interpretative quantitation, and their relevance in infection imaging.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. O’Connor MK, Kemp BJ. Single-photon emission computed tomography/computed tomography: basic instrumentation and innovations. Semin Nucl Med. 2006;36(4):258–66. https://doi.org/10.1053/j.semnuclmed.2006.05.005.

    Article  PubMed  Google Scholar 

  2. Bunyaviroch T, Aggarwal A, Oates ME. Optimized scintigraphic evaluation of infection and inflammation: role of single-photon emission computed tomography/computed tomography fusion imaging. Semin Nucl Med. 2006;36(4):295–311. https://doi.org/10.1053/j.semnuclmed.2006.05.004.

    Article  PubMed  Google Scholar 

  3. Townsend DW. Positron emission tomography/computed tomography. Semin Nucl Med. 2008;38(3):152–66. https://doi.org/10.1053/j.semnuclmed.2008.01.003.

    Article  PubMed  Google Scholar 

  4. Patton JA, Townsend DW, Hutton BF. Hybrid imaging technology: from dreams and vision to clinical devices. Semin Nucl Med. 2009;39(4):247–63. https://doi.org/10.1053/j.semnuclmed.2009.03.005.

    Article  PubMed  Google Scholar 

  5. Khafif A, Schneebaum S, Fliss DM, Lerman H, Metser U, Ben-Yosef R, et al. Lymphoscintigraphy for sentinel node mapping using a hybrid single photon emission CT (SPECT)/CT system in oral cavity squamous cell carcinoma. Head Neck. 2006;28(10):874–9. https://doi.org/10.1002/hed.20434.

    Article  PubMed  Google Scholar 

  6. Lerman H, Lievshitz G, Zak O, Metser U, Schneebaum S, Even-Sapir E. Improved sentinel node identification by SPECT/CT in overweight patients with breast cancer. J Nucl Med. 2007;48(2):201–6.

    PubMed  Google Scholar 

  7. Krausz Y, Keidar Z, Kogan I, Even-Sapir E, Bar-Shalom R, Engel A, et al. SPECT/CT hybrid imaging with 111In-pentetreotide in assessment of neuroendocrine tumours. Clin Endocrinol. 2003;59(5):565–73.

    Article  Google Scholar 

  8. Perri M, Erba P, Volterrani D, Lazzeri E, Boni G, Grosso M, et al. Octreo-SPECT/CT imaging for accurate detection and localization of suspected neuroendocrine tumors. Q J Nucl Med Mol Imaging. 2008;52(4):323–33.

    CAS  PubMed  Google Scholar 

  9. Pfannenberg AC, Eschmann SM, Horger M, Lamberts R, Vonthein R, Claussen CD, et al. Benefit of anatomical-functional image fusion in the diagnostic work-up of neuroendocrine neoplasms. Eur J Nucl Med Mol Imaging. 2003;30(6):835–43. https://doi.org/10.1007/s00259-003-1160-y.

    Article  PubMed  Google Scholar 

  10. Horger M, Eschmann SM, Pfannenberg C, Storek D, Dammann F, Vonthein R, et al. The value of SPET/CT in chronic osteomyelitis. Eur J Nucl Med Mol Imaging. 2003;30(12):1665–73. https://doi.org/10.1007/s00259-003-1321-z.

    Article  PubMed  Google Scholar 

  11. Weon YC, Yang SO, Choi YY, Shin JW, Ryu JS, Shin MJ, et al. Use of Tc-99m HMPAO leukocyte scans to evaluate bone infection: incremental value of additional SPECT images. Clin Nucl Med. 2000;25(7):519–26.

    Article  CAS  Google Scholar 

  12. Sanli Y, Ozkan ZG, Unal SN, Turkmen C, Kilicoglu O. The additional value of Tc 99m HMPAO white blood cell SPECT in the evaluation of bone and soft tissue infections. Mol Imaging Radionuclide Ther. 2011;20(1):7–13. https://doi.org/10.4274/mirt.20.02.

    Article  Google Scholar 

  13. Filippi L, Schillaci O. Usefulness of hybrid SPECT/CT in 99mTc-HMPAO-labeled leukocyte scintigraphy for bone and joint infections. J Nucl Med. 2006;47(12):1908–13.

    CAS  PubMed  Google Scholar 

  14. Bar-Shalom R, Yefremov N, Guralnik L, Keidar Z, Engel A, Nitecki S, et al. SPECT/CT using 67Ga and 111In-labeled leukocyte scintigraphy for diagnosis of infection. J Nucl Med. 2006;47(4):587–94.

    PubMed  Google Scholar 

  15. Even-Sapir E, Keidar Z, Bar-Shalom R. Hybrid imaging (SPECT/CT and PET/CT)—improving the diagnostic accuracy of functional/metabolic and anatomic imaging. Semin Nucl Med. 2009;39(4):264–75. https://doi.org/10.1053/j.semnuclmed.2009.03.004.

    Article  PubMed  Google Scholar 

  16. Seo Y, Mari C, Hasegawa BH. Technological development and advances in single-photon emission computed tomography/computed tomography. Semin Nucl Med. 2008;38(3):177–98. https://doi.org/10.1053/j.semnuclmed.2008.01.001.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Fricke H, Fricke E, Weise R, Kammeier A, Lindner O, Burchert W. A method to remove artifacts in attenuation-corrected myocardial perfusion SPECT Introduced by misalignment between emission scan and CT-derived attenuation maps. J Nucl Med. 2004;45(10):1619–25.

    PubMed  Google Scholar 

  18. Goetze S, Wahl RL. Prevalence of misregistration between SPECT and CT for attenuation-corrected myocardial perfusion SPECT. J Nucl Cardiol. 2007;14(2):200–6. https://doi.org/10.1016/j.nuclcard.2006.12.325.

    Article  PubMed  Google Scholar 

  19. Ruf J, Steffen I, Mehl S, Rosner C, Denecke T, Pape UF, et al. Influence of attenuation correction by integrated low-dose CT on somatostatin receptor SPECT. Nucl Med Commun. 2007;28(10):782–8. https://doi.org/10.1097/MNM.0b013e3282efa1a9.

    Article  PubMed  Google Scholar 

  20. Steffen IG, Mehl S, Heuck F, Elgeti F, Furth C, Amthauer H, et al. Attenuation correction of somatostatin receptor SPECT by integrated low-dose CT: is there an impact on sensitivity? Clin Nucl Med. 2009;34(12):869–73. https://doi.org/10.1097/RLU.0b013e3181becfcb.

    Article  PubMed  Google Scholar 

  21. Ruf J, Seehofer D, Denecke T, Stelter L, Rayes N, Felix R, et al. Impact of image fusion and attenuation correction by SPECT-CT on the scintigraphic detection of parathyroid adenomas. Nuklearmedizin. 2007;46(1):15–21.

    Article  CAS  Google Scholar 

  22. Signore A, Jamar F, Israel O, Buscombe J, Martin-Comin J, Lazzeri E. Clinical indications, image acquisition and data interpretation for white blood cells and anti-granulocyte monoclonal antibody scintigraphy: an EANM procedural guideline. Eur J Nucl Med Mol Imaging. 2018; https://doi.org/10.1007/s00259-018-4052-x.

  23. Erba PA, Isreal O. SPECT/CT in infection and inflammation. Clin Transl Imaging. 2014;2:519–35.

    Article  Google Scholar 

  24. Pelosi E, Baiocco C, Pennone M, Migliaretti G, Varetto T, Maiello A, Bellò M, Bisi G. 99mTc-HMPAO-leukocyte scintigraphy in patients with symptomatic total hip or knee arthroplasty: improved diagnostic accuracy by means of semiquantitative evaluation. J Nucl Med. 2004;45:438–44.

    PubMed  Google Scholar 

  25. Conti F, Malviya G, Ceccarelli F, Priori R, Iagnocco A, Valesini G, Signore A. Role of scintigraphy with 99mTc-infliximab in predicting the response of intraarticular infliximab treatment in patients with refractory monoarthritis. Eur J Nucl Med Mol Imaging. 2012;39:1339–47.

    Article  CAS  Google Scholar 

  26. Glaudemans AWJM, Bonanno E, Galli F, Zeebregts CJ, de Vries EFJ, Koole M, Luurtsema G, Boersma HH, Taurino M, Slart RHJA, Signore A. In vivo and in vitro evidence that 99mTc-HYNIC-interleukin-2 is able to detect T lymphocytes in vulnerable atherosclerotic plaques of the carotid artery. Eur J Nucl Med Mol Imaging. 2014;41:1710–9.

    Article  CAS  Google Scholar 

  27. Strauss HW, Grewal RK, Pandit-Taskar N. Molecular imaging in nuclear cardiology. Semin Nucl Med. 2004;34:47–55.

    Article  Google Scholar 

  28. De Laroche R, Simon E, Suignard N, Williams T, Henry MP, et al. Clinical interest of quantitative bone SPECT-CT in the preoperative assessment of knee osteoarthritis. Medicine (Baltimore). 2018;97(35):e11943.

    Article  Google Scholar 

  29. https://www.hermesmedical.com/products/suv-spect-reconstruction-absolute-quantification/

  30. Rahmim A, Zaidi H. PET versus SPECT: strengths, limitations and challenges. Nucl Med Commun. 2008;29(3):193–207. https://doi.org/10.1097/MNM.0b013e3282f3a515.

    Article  PubMed  Google Scholar 

  31. Hess S, Alavi A, Basu S. PET-Based personalized management of infectious and inflammatory disorders. PET Clin. 2016;11(3):351–61. https://doi.org/10.1016/j.cpet.2016.02.008.

    Article  PubMed  Google Scholar 

  32. van der Vos CS, Koopman D, Rijnsdorp S, Arends AJ, Boellaard R, van Dalen JA, et al. Quantification, improvement, and harmonization of small lesion detection with state-of-the-art PET. Eur J Nucl Med Mol Imaging. 2017;44(Suppl 1):4–16. https://doi.org/10.1007/s00259-017-3727-z.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Metser U, Lerman H, Blank A, Lievshitz G, Bokstein F, Even-Sapir E. Malignant involvement of the spine: assessment by 18F-FDG PET/CT. J Nucl Med. 2004;45(2):279–84.

    PubMed  Google Scholar 

  34. Nakamoto Y, Cohade C, Tatsumi M, Hammoud D, Wahl RL. CT appearance of bone metastases detected with FDG PET as part of the same PET/CT examination. Radiology. 2005;237(2):627–34. https://doi.org/10.1148/radiol.2372031994.

    Article  PubMed  Google Scholar 

  35. Taira AV, Herfkens RJ, Gambhir SS, Quon A. Detection of bone metastases: assessment of integrated FDG PET/CT imaging. Radiology. 2007;243(1):204–11. https://doi.org/10.1148/radiol.2431052104.

    Article  PubMed  Google Scholar 

  36. Even-Sapir E, Metser U, Flusser G, Zuriel L, Kollender Y, Lerman H, et al. Assessment of malignant skeletal disease: initial experience with 18F-fluoride PET/CT and comparison between 18F-fluoride PET and 18F-fluoride PET/CT. J Nucl Med. 2004;45(2):272–8.

    PubMed  Google Scholar 

  37. Jamar F, Buscombe J, Chiti A, Christian PE, Delbeke D, Donohoe KJ, et al. EANM/SNMMI guideline for 18F-FDG use in inflammation and infection. J Nucl Med. 2013;54(4):647–58. https://doi.org/10.2967/jnumed.112.112524.

    Article  PubMed  Google Scholar 

  38. Palestro CJ. The current role of gallium imaging in infection. Semin Nucl Med. 1994;24(2):128–41.

    Article  CAS  Google Scholar 

  39. Segard T, Morandeau LM, Dunne ML, Robinson JO, Murray RJ, Geelhoed EA, et al. Comparison between Gallium-68 citrate PET-CT and Gallium-67 citrate scintigraphy for infection imaging. Intern Med J. 2019; https://doi.org/10.1111/imj.14231.

  40. Auletta S, Varani M, Horvat R, Galli F, Signore A, Hess S. PET radiopharmaceuticals for specific bacteria imaging: a systematic review. J Clin Med. 2019;8(2) https://doi.org/10.3390/jcm8020197.

  41. Glaudemans AWJM, Galli F, Pacilio M, Signore A. Leukocyte and bacteria imaging in prosthetic joint infection. Eur Cell Mater. 2013;25:61–77.

    Article  Google Scholar 

  42. Rabkin Z, Israel O, Keidar Z. Do hyperglycemia and diabetes affect the incidence of false-negative 18F-FDG PET/CT studies in patients evaluated for infection or inflammation and cancer? A comparative analysis. J Nucl Med. 2010;51:1015–20.

    Article  Google Scholar 

  43. Eskian M, Alavi A, Khorasanizadeh M, Viglianti BL, Jacobsson H, et al. Effect of blood glucose level on standardized uptake value (SUV) in 18F-FDG PET-scan: a systematic review and meta-analysis of 20,807 individual SUV measurements. Eur J Nucl Med Mol Imaging. 2019;46:224–37.

    Article  CAS  Google Scholar 

  44. Jamar F, Buscombe J, Chiti A, Christian PE, Delbeke D, Donohoe KJ, Israel O, Martin-Comin J, Signore A. EANM/SNMMI guideline for 18F-FDG use in inflammation and infection. J Nucl Med. 2013;54:647–58.

    Article  Google Scholar 

  45. Chin BB, Lyengar S, Sabundayo BP, Schwartz D. Standardized uptake values in 2-Deoxy-2-[18F]Fluoro-D-glucose with positron emission tomography: clinical significance of iterative reconstruction and segmented attenuation compared with conventional filtered back projection and measured attenuation correction. Mol Imaging Biol. 2002;4:294–300.

    Article  Google Scholar 

  46. Hungenbach S, Delank KS, Dietlein M, Eysel P, Drzezga A, Schmidt MC. 18F-fluorodeoxyglucose uptake pattern in patients with suspected spondylodiscitis. Nucl Med Commun. 2013;34:1068–74.

    Article  CAS  Google Scholar 

  47. van der Valk FM, Verweij SL, Zwinderman KAH, Strang AC, et al. Thresholds for arterial wall inflammation quantified by 18F-FDG PET imaging. JACC Cardiovasc Imaging. 2016;9:1198–207.

    Article  Google Scholar 

  48. Lemans JVC, Hobbelink MGG, IJpma FFA, Plate JDT, van den Kieboom J, Bosch P, Leene LPH, Glaudemans AWJM, Govaert GAM. The diagnostic accuracy of 18F-FDG PET/CT in diagnosing fracture-related infections. Eur J Nucl Med Mol Imaging. 2019;46:999–1008.

    Article  CAS  Google Scholar 

  49. Nanni C, Boriani L, Salvadori C, Zamparini E, Rorato G, Ambrosini V, et al. FDG PET/CT is useful for the interim evaluation of response to therapy in patients affected by haematogenous spondylodiscitis. Eur J Nucl Med Mol Imaging. 2012;39:1538–44.

    Article  Google Scholar 

  50. Husmann L, Huellner MW, Ledergerber B, et al. Comparing diagnostic accuracy of 18F-FDG-PET/CT, contrast enhanced CT and combined imaging in patients with suspected vascular graft infections. Eur J Nucl Med Mol Imaging. 2019;46:1359–68.

    Article  CAS  Google Scholar 

  51. Husmann L, Sah BR, Scherrer A, Burger IA, Stolzmann P, Weber R, Rancic Z, Mayer D, Hasse B, Cohort VASGRA. ¹8F-FDG PET/CT for therapy control in vascular graft infections: a first feasibility study. J Nucl Med. 2015;56:1024–9.

    Article  Google Scholar 

  52. Hess S, Hansson SH, Pedersen KT, Basu S, Høilund-Carlsen PF. FDG-PET/CT in infectious and inflammatory diseases. PET Clin. 2014;9:497–519.

    Article  Google Scholar 

  53. Houshmand S, Salavati A, Hess S, Werner TJ, Alavi A, Zaidi H. An update on novel quantitative techniques in the context of evolving whole-body PET imaging. PET Clin. 2015;10:45–58.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Auletta, S., Christensen, T.Q., Hess, S. (2020). Hybrid SPECT/CT and PET/CT Imaging in Infectious Diseases. In: Signore, A., Glaudemans, A. (eds) Nuclear Medicine in Infectious Diseases. Springer, Cham. https://doi.org/10.1007/978-3-030-25494-0_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-25494-0_4

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-25493-3

  • Online ISBN: 978-3-030-25494-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics